Connect your AI

Microbot Medical MBOT Payments To Acquire Restricted Investments

Payments To Acquire Restricted Investments at other companies

DocGoDCGO

$1.73M—

Avis Budget GroupCAR

$13M—

Nutex Health Inc.NUTX

$0-100%

Security National Financial CorporationSNFCA

$2.09M+124%

Barrett Business ServicesBBSI

$1.43M-95.8%

Under ArmourUAA

$150.31M—

Other financials

Income statement

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireRestrictedInvestments.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's payments to acquire restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Microbot Medical's payments to acquire restricted investments?: Microbot Medical (MBOT) reported payments to acquire restricted investments of $806K in Q1 2026.